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1. INTRODUCTION 
 
Intrauterine Growth restriction (IUGR) is a common complication of pregnancy that 
carries significant short and long-term sequelae that reaches out to adulthood.
1
 Next to 
preterm birth, IUGR is the second leading cause of perinatal mortality.  
 
Intra-Uterine Growth Retardation (IUGR) is failure to attain optimal intrauterine 
growth which is defined as either birth weight less than the 10th percentile for 
gestational age or as birth weight less than 2 standard deviations below the mean 
value for gestational age. 
 
When compared with normally grown fetuses after exclusion of aneuploidic and 
anomalous fetuses, mortality rates are increased 10-fold with perinatal mortality rates 
as high as 120 per 1000 for all cases of IUGR. As many as 53% of preterm stillbirths 
and 26% of term stillbirths are growth restricted. Up to 50% of survivors will 
experience intrapartum asphyxia, which adds to the already increased risk of end-
organ injury.  
 
However, the IUGR condition provides numerous challenges to both researchers of 
the condition and the clinician caring for the patient and includes the following: 
varied etiologies and definitions, altered fetal behavioral and vascular responses to 
IUGR, severely limited treatment options and uncertainty regarding the timing of 
delivery. 
 
. 
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2. JUSTIFICATION 
 
Intrauterine growth restriction (IUGR) is an important clinical problem associated 
with increased perinatal mortality and morbidity. The neonate may be either 
constitutionally small or small due to pathophysiological changes with maternal, 
placental or fetal factors involved. A fetus with IUGR has not achieved its genetic 
growth potential.  
 
Intra uterine growth-retarded babies face problems not of immaturity, but of in-utero 
hypoxia, poor nutrition and the resultant stress. There is a substantial overlap between 
their problems and those that premature babies face. The effects of this 
disadvantageous start, however, tend to persist. IUGR babies exhibit poor catch-up 
growth and impaired cognitive and neurobehavioral development. In addition, 
emerging evidence
2
 suggests that they are also more likely than normal weight babies 
to suffer from degenerative diseases like hypertension, diabetes and cardiovascular 
diseases in adulthood. 
 
Given the immediate and long-term implications of IUGR and its high prevalence in 
India, a focus on IUGR is both rational and strategic from a public health perspective. 
A 20% approximate prevalence of IUGR in India implies that it is a significant public 
health problem.
3
 IUGR is strategic from the point of view of neonatal and infant 
mortality and adulthood morbidity. So this study attempts to find the maternal and 
fetal risk factors and mortality and morbidity pattern of IUGR babies admitted in a 
tertiary care hospital.  
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3. AIMS AND OBJECTIVES 
 
The Aims and Objectives of the study are:  
 
1) To study the Clinical profile of IUGR babies admitted in the Sick Neonatal 
Nursery of Tirunelveli Medical College Hospital and their Outcome during 
hospital stay.   
 
2) To find out the Maternal and Fetal risk factors and their association with 
morbidity and mortality pattern of IUGR babies.   
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4. LITERATURE REVIEW 
1.0 INTRODUCTION 
1.1 Definitions 
Intrauterine Growth Restriction 
Intra-Uterine Growth Retardation (IUGR) is failure to attain optimal intrauterine 
growth which is defined as either birth weight less than the 10th or 5th percentile for 
gestational age or as birth weight less than 2 standard deviations below the mean 
value for gestational age. In IUGR the rate of fetal growth that is less than normal for 
the population and for the growth potential of a specific infant. IUGR therefore 
produces infants who are SGA. SGA infants can be the result of normal but slower 
than average rates of fetal growth, such as those constitutionally small but not 
abnormal infants whose parents, siblings, and more distant relatives are small.
4
 SGA 
infants also can be the result of abnormally slow fetal growth that is caused by 
pathophysiologic conditions or diseases. Because growth is one of the essential 
features of the fetus, nearly any aberration of biologic activity in the fetus can lead to 
growth failure. Thus, small size at birth can be either a normal outcome or one that is 
a result of intrinsic or extrinsic factors that limit fetal growth potential. 
 
Small for Gestational Age 
SGA infants are classically defined as having a birth weight that is more than two 
standard deviations below the mean or less than the 10
th
 percentile of a population-
specific birth weight vs. gestational age plot. Broader definitions include less than 
normal anthropometric indexes, such as length and head circumference, and marked 
differences between growth parameters, even when they are within the normal range. 
10 
 
For example, an infant can be considered “relatively” SGA when its weight is at the 
25th percentile, but its length and head circumference are at the 75th percentile. In 
this case, the weight/length ratio (or the Ponderal index = [weight (g)]/[length (cm)]3) 
is less than normal, indicating that growth rates of adipose tissue and skeletal muscle, 
the principal determinants of weight, were less than normal.
5 
 
1.2 Symmetric and Asymmetric Intra Uterine Growth Restriction 
IUGR can be sub-divided into two categories: 
a. Disproportional/Asymmetric or wasted IUGR: this is characterized by a 
normal height and head circumference (approximates to brain growth) and low 
weight for height and skin fold measurements. The ponderal index (PI) for such 
babies is less than 2. This kind of IUGR is generally assumed to be the result of 
poor fetal nutrition later rather than earlier in pregnancy. 
b. Proportional/ Symmetric or stunted IUGR: this is characterized by 
proportionally low weight, height and head circumference. The PI for such 
babies is approximately 2-2.5. This is more likely to occur if the nutritional insult 
occurs earlier in gestation. 
 
Symmetric IUGR implies that brain and body growth both are limited. Asymmetric 
growth indicates that body growth is restricted to a much greater extent than head 
(and thus, brain) growth. In such cases, brain growth is considered “spared.” 
Mechanisms that allow brain growth to continue at a faster rate than adipose tissue 
and skeletal muscle are not completely known. Contributing factors may include an 
increased rate of cerebral blood flow relative to the umbilical and systemic 
circulations, which has been observed in some of these infants.
6 
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1.3 Prevalence of IUGR 
At least 13.7 million infants are born every year at term with low birth weight (LBW), 
representing 11% of all newborns in developing countries. This rate is approximately 
6 times higher than in developed countries. LBW, defined as < 2500 g, affects 16.4% 
of all newborns, or about 20.5 million infants each year. IUGR, defined as birth 
weight below the 10th percentile of the birth-weight-for-gestational-age reference 
curve, represents 23.8%, or approximately 30 million newborns per year.
7 
 
Very few studies in developing countries distinguish between the sub- types of 
LBW.
8,9
 Villar and Belizan
10
 have estimated that 55% of LBW in developed countries 
is due to prematurity on the basis of an analysis of data from 11 different regions in 
developed countries and 25 areas in developing countries. In developing countries 
they estimate that approximately 70% of the low birth weight is due to IUGR. Other 
studies arrive at similar estimates for India. Recent multicentric data (37000 live 
births) suggests that 67.2% of all LBW babies in India are IUGR.
9
  
 
Another estimate suggested that 55% to 70% of babies in the 1501 to 2000 g category 
and 85% to 87% in the 2000 to 2500 g category are IUGR. According to de Onis et al 
approximately 20% of all Indian babies born are IUGR. This is more than two-thirds 
of the total LBW incidence.
3
 All of these estimates are likely to be fairly conservative 
since home deliveries tend to get left out of such enumerations. It is worthy to note 
that 65.4% of deliveries in India take place at home (NFHS-2). 
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2.0 RISK FACTORS ASSOCIATED WITH IUGR 
2.1 Fetal Causes 
Fetal causes are varied and range from genetic and structural malformations to 
infections. 
Genetic diseases 
Genetic diseases of the fetus constitute 5% to 20% of causes of IUGR.
11
 
Chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18 
(Edwards syndrome), trisomy 13 (Patau syndrome), and many others, can cause 
growth restriction presumably through the reduced number of small muscular arteries 
in the tertiary stem villi. Up to 16% of cases of IUGR have been associated with 
confined placental mosaicism. Maternal genotype is more important than fetal 
genotype in the overall regulation of fetal growth. However, the paternal genotype is 
essential for trophoblast development, which  secondarily regulates fetal growth by 
the provision of nutrients.
12 
 
Fetal infections 
Fetal infections are responsible for up to 10% of growth restriction cases.  The 
TORCH [Toxoplasmosis, Other (Syphilis), Rubella, Cytomegalovirus and Herpes] 
organisms have been historically considered as the group to evaluate.
13
 Presently, the 
most common causes are toxoplasmosis and cytomegalovirus in developed countries, 
and they should be the ones tested for most frequently. Rubella is less of a threat due 
to vaccination. Syphilis is still being encountered in pregnancy both in developed and 
developing countries. Malaria is the predominant infectious cause in Africa, South-
East Asia, and other countries where malaria is endemic, accounting for 40% of 
cases.
14 
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Multiple gestations 
Multiple gestations are associated with about 3% of cases of IUGR. The risk of 
mortality or neonatal morbidity is higher among neonates in SGA-discordant twins 
than in AGA (appropriate for gestational age)-discordant twins (20% versus 6%).20 
Growth restriction is a determinant of outcome in preterm discordant twins.
15 
 
TABLE 1 - Factors Associated with Intrauterine Growth Restriction 
 
Fetal 
 
 Chromosomal disorders (autosomal trisomies) 
 
 Chronic fetal infections (cytomegalic inclusion disease, congenital rubella, 
syphilis) 
 
 Congenital anomalies—syndrome complexes 
 
 Irradiation 
 
 Multiple gestation 
 
 Pancreatic hypoplasia 
 
 Insulin deficiency 
 
 Insulin-like growth factor type I deficiency 
Infection (eg, CMV, toxoplasmosis, malaria, rubella) 
 
Placental 
 
 Decreased placental weight or cellularity, or both 
 
 Decrease in surface area 
 
 Villous placentitis (bacterial, viral, parasitic) 
 
 Infarction 
 
 Tumor (chorioangioma, hydatidiform mole) 
 
 Placental separation 
 
 Twin transfusion syndrome 
 
Maternal 
  Toxemia 
 
 Hypertension or renal disease, or both 
14 
 
 
 Hypoxemia (high altitude, cyanotic cardiac or pulmonary disease) 
 
 Malnutrition (micro- or macronutrient deficiencies) 
 
 Chronic illness 
 
 Sickle cell anemia 
 
 Drugs (narcotics, alcohol, cigarettes, cocaine, antimetabolites) 
Hypertensive disorders  
Pregestational diabetes 
Autoimmune disease (eg, APS, SLE) 
Cardiac disease (eg, complex cyanotic congenital heart diseases) 
Toxic exposure (smoking, alcohol, cocaine, drugs) 
Malnutrition 
Short inter pregnancy interval 
 
Socio demographic 
       Living at high altitudes 
       Living in developing country 
       Low socio-economic status 
 Extremes of maternal age (less than 16 or over 35) 
       Low socioeconomic status 
       Low maternal weight for height 
       Low maternal weight at her birth 
       Maternal short stature 
 Smoking, alcohol or drug usage 
 
2.2 Maternal Causes 
Maternal causes of IUGR are usually related to reduced uteroplacental blood flow, 
reduced maternal blood volume, reduced oxygen-carrying capacity, or decreased 
nutrition to the fetus. Often the etiology is associated with more than one of these 
mechanisms. 
Fetal development is the product of the interaction between genetic potential and the 
uterine environment. The nature of this interaction is such that the achievement of 
inherited genetic potential is essentially mediated by the intra-uterine environment.
16
 
Evidence for the mediating role of the maternal environment comes from kinship 
studies. 
15 
 
According to Jane Harding
17
, fetal nutrition is the end result of a precarious supply 
chain, of which maternal nutrition and intake during pregnancy is only the starting 
point. This chain can be synopsised as:    
Maternal diet  Maternal metabolic and endocrine status Uterine blood flow   
Placental factors that impinge on transport and metabolism  Umbilical blood flow  
 Fetal metabolic and endocrine status. 
 
The set of factors that could potentially influence the fetal supply line may be 
classified into: 
(a) Maternal nutritional factors: maternal nutritional status can be proxied by 
several variables across the female lifecycle. These proxies include maternal 
height, pre-pregnancy weight and gestational weight gain. 
(b) Maternal non-nutritional factors: these include parity, maternal morbidity 
during pregnancy including malaria and episodic illness and toxic exposures 
to tobacco and alcohol. 
 
Decreased Nutrition 
Because glucose drives and is essential for fetal growth, prepregnancy maternal 
weight and maternal weight gain in pregnancy are important variables contributing to 
birth weight. Thus, poor weight gain or low prepregnancy weight (associated with 
decreased nutrition to the fetus) can be associated with IUGR. It has been shown that 
protein restriction rather than caloric restriction before 26 weeks can cause symmetric 
IUGR. On the contrary, high protein supplementation is associated with an increase in 
the incidence of FGR as well as neonatal death. Gastrointestinal diseases, such as 
Crohn’s disease, ulcerative colitis, and gastrointestinal bypass surgery, can cause 
16 
 
lower birth weight because of decreased nutrition to the fetus, although IUGR is not 
necessarily increased with these conditions. 
 
Gestational weight gain 
Gestational weight gain refers to maternal weight gain across the period of pregnancy. 
This can be understood either in aggregate terms or in terms of unit of weight gain per 
week or across the first, second and third trimesters. A WHO multi-centric study 
identified attained (maternal and fetal) weight at 20 weeks and at 36 weeks of 
gestation as a good predictor of IUGR.
18
 Kramer’s classic meta-analysis
8
 reported a 
positive relationship between gestational weight gain and gestational-age-adjusted 
birth weight. Strauss et al.
19
 in their literature review and analysis of two cohorts 
present substantial evidence on the importance of adequate weight gain during the 
second trimester of pregnancy. This remains true even when overall weight gain was 
adequate during pregnancy. Low weight gain in the second or third trimesters was 
associated with approximately double the risk of IUGR. 73% to 82% of all patients 
with inadequate weight gain in the second and third trimesters had normal weight gain 
overall. A study by Scholl et al.
20
 highlights a two-fold increase in IUGR when weight 
gain is low in the second trimester. 
 
Gestational weight gain is found to interact very closely with pre-pregnancy weight 
gain. Miller et al.
21
 reported that IUGR rates increased among women with low 
gestational weight gain as their pre-pregnancy weight for height decreased. This 
implies that in developing countries with a low pre-pregnancy weight and gestational 
weight gain of less than 7 kg, the relative risk of poor gestational weight gain for 
IUGR is much higher. 
17 
 
 
The exact mechanism by which gestational weight gain affects fetal growth is not 
clear and it has been used largely as a rough indicator of fetal growth. Gestational 
weight gain is a function of (a) the physiological process of pregnancy and fetal 
growth i.e. plasma volume and amniotic fluid expansion, growth of uterine tissue, of 
the fetus and placenta etc, and (b) the laying down of fat stores. The fat stores laid 
down ultimately impact fetal growth rate but do not indicate the growth rate at a 
particular point in time. 
 
Parity 
It is correlated with birth weight such that higher parity is accompanied by an increase 
in mean birth weight. Kramer’s meta analysis found a sample size weighted effect of 
43.3 g on birth weight per birth associated with parity. It estimated a relative risk of 
1.23 for IUGR associated with primi parity.
22
 In the Indian context, according to the 
NFHS-2 an estimated 29% of births are first order births. This is indicative of the 
proportion of all births exposed to the risk of IUGR associated with primi parity. 
 
Maternal morbidity 
Maternal morbidity in terms of general episodic illnesses and malaria has been found 
to have a significant impact on the incidence of IUGR. The mechanisms by which 
bouts of such illnesses could impact the incidence of IUGR may be: reduction of food 
intake, metabolic cost of the illness and reduction in uterine blood flow. 
 
In India the most commonly reported health problem during pregnancy is excessive 
fatigue. According to the NFHS-2, 43% of the respondents experienced excessive 
18 
 
fatigue during pregnancy. This may be linked to the fact that 35.8% of women in the 
reproductive age group have a body mass index of less than 18.5 kg/m2, which is 
indicative of chronic energy deficiency.
23 
 
Toxic exposures 
Maternal toxic exposures through smoking or tobacco consumption and alcohol intake 
are found to have deleterious effects on fetal growth. Studies are unanimous regarding 
the effects of smoking on fetal growth. It estimated a relative risk of 2.42 for IUGR 
associated with smoking.
8
 Cigarette smoking can affect intrauterine growth through 
the effects of carbonmonoxide and nicotine. Carbonmonoxide affects the supply of 
oxygen to the fetus while nicotine is an appetite suppressant and constricts uterine 
blood vessels. The effect of smoking on birth weight is more marked for the last 
trimester. For India, the prevalence rates for the use of smokeless tobacco by women 
in general vary from 0.2 % in the state of Punjab to 33.2 % in Arunachal Pradesh to 
60.7% in Mizoram. However, overall prevalence of smoking and use of smokeless 
tobacco among women is approximately 3% and 12.4% respectively. 
 
Alcohol consumption impacts IUGR by causing fetal hypoxia or decreasing the 
incorporation of amino acids from protein. Kramer found that consumption of 2 
drinks or more per day decreases birth weight by 155 g. The relative risk for IUGR 
associated with the consumption of 2 or more drinks per day was 1.8. Exposure to 
absolute alcohol in the latter stages of pregnancy is found to have a relatively greater 
impact. Consumption of alcohol by women (above 15 yr.) in India also varies by state 
but at a national level is 2.2% in general and 4.4% for women of a low socio-
economic status. 
19 
 
Teratogens 
Prescription medications such as coumadin and hydantoin derivatives as well as 
alcohol abuse are definitely associated with certain dysmorphic features as well as 
impaired fetal 
growth. Maternal illicit drug use will cause IUGR by its association with poor diet as 
well as a probable direct effect. Use of heroin40 or cocaine is associated with IUGR 
in 50% and 30%, respectively, of cases. 
 
2.3 Placental Factors 
The size of the placenta and its directly related nutrient transport functions are the 
principal regulators of nutrient supply to the fetus and thus the rate of fetal growth. 
Nearly all cases of IUGR are associated with a smaller-than-normal placenta.
24 
 
Decreased Uteroplacental Blood Flow 
Maternal diseases that affect blood circulation will result in decreased uteroplacental 
blood flow and are to blame for the majority of IUGR cases. These diseases include 
hypertensive disorders (gestational and nongestational), diabetes, chronic renal 
disease such as renal insufficiency, systemic lupus erythematosus, antiphospholipid 
syndrome, and others. Acquired thrombophilias, such as anticardiolipin antibodies 
and lupus anticoagulant, can cause poor pregnancy outcomes such as early-onset 
preeclampsia and fetal demise in addition to IUGR. 
 
Reduced Blood Volume 
Women who live at high altitudes or have genetic conditions such as angiotensinogen 
gene mutations will have compromised placental blood flow because of reduced 
blood volume from poor pregnancy-associated volume expansion. 
20 
 
 
Reduced Oxygen-Carrying Capacity 
Women who smoke, live at high altitudes
25
, or have cyanotic heart disease, 
parenchymal lung disease, hemoglobinopathies, and anemias will have decreased 
oxygen carrying capacity which can result in IUGR. Smoking causes symmetric 
IUGR not only because of a reduction in oxygen-carrying capacity, but also because 
of impaired uterine blood flow. 
 
At more advanced stages of placental development, placental production of growth 
factors and growth regulating hormones develops, leading to significant autocrine 
regulation of placental growth and placental regulation of fetal growth processes. 
Human placental lactogen is synthesized and secreted by the syncytiotrophoblast cells 
of the placenta.
26
 Fetal growth-promoting actions of placental lactogen are mediated 
by stimulation of IGF production in the fetus and by increasing the availability of 
nutrients to fetal tissues.
27
 Obviously, placental growth failure and/or nutrient deficit 
to the placenta can result in decreased placental production of growth factors that then 
would lead to fetal growth failure. 
 
2.4 Socio-demographic factors 
Maternal Age 
Parity interacts with age, such that multi parity increases the risk of LBW for women 
aged less than 20, has little effect on women aged 20-34 and substantially decreases 
the risk of LBW for women more than 35 years in age. Thus the risk group from the 
standpoint of parity-age interaction is young multi parae.
28 
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Maternal height 
Evidence for the independent causal effect of maternal height on IUGR comes from 
Kramer’s meta-analysis.
8
 The meta-analysis estimated a sample size weighted effect 
of 7.8 g on birth weight for every centimetre of maternal height. It calculated a 
relative risk (RR) of 1.27 for IUGR associated with a maternal height of less than 
157.5-158 cm. 
 
For the Indian population with a mean maternal height of 152 cm and therefore an 
84% prevalence of women less than 158 cm in height, the above findings imply that a 
maternal height of less than 158 cm may be responsible for 18% of the IUGR. The 
influence of maternal height on IUGR may be through a genetic mechanism or due to 
the physical limitations imposed on the growth of the uterus, placenta and the fetus. 
Maternal height is itself a function of the interaction between inherited genetic 
potential and the intra and extra-uterine environment. Malnutrition during uterine 
growth and the first two to three years of life leads to the onset of stunting which is 
not completely reversed even with long term exposure to good nutrition.
29
 The 
prevention of maternal stunting appears to be a necessary element of the package of 
interventions required to reduce IUGR. Intervening to prevent maternal stunting 
would require a focus on both intra-uterine growth and development during the first 
two years of life. Improvement in maternal height through these interventions is 
essentially possible only in the long term. 
 
Maternal pre-pregnancy weight 
Maternal pre-pregnancy weight has been identified as one of the best predictors of 
potential IUGR.
9
 Kramer’s meta-analysis
8
 found a sample size weighted independent 
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effect of 9.5 g on birth weight for every 1 kg of maternal pre-pregnancy weight. It 
estimated an odds ratio (OR) of 1.84 for IUGR associated with a pre-pregnancy 
weight of less than 49.5 kg for developed countries. For the Indian context there is 
some controversy about the threshold of pre-pregnancy weight below which the 
relative risk for IUGR is greater than 1. An Indian Council of Medical Research 
multicentric study recorded a pre-pregnancy weight of less than 40 kg as an 
influencing determinant
30
 while Viller et al. found a pre-pregnancy weight of less than 
45 kg as significant.
10
 The mean weight of Indian women in the reproductive age 
group (15-49) is 46.4kg. 
 
It has been proposed that female under nutrition across the lifecycle could harm fetal 
growth through its effects on maternal metabolic and endocrine status.
17
 This 
ultimately impacts the fetus’s access to nutrients. The above evidence points to the 
potential importance of ensuring adequate pre-pregnancy weight in the process of 
reducing IUGR incidence. Interventions to improve pre-pregnancy weight would 
imply a focus on the nutrient intake of women of the reproductive age group, with an 
emphasis on the period of the adolescent growth spurt. 
 
The prevalence and effect magnitude of the factors in the Indian context may be 
summarised as in the following table.  
 
Table 2: Showing Risks factors for IUGR and their prevalence in India. 
23 
 
 
 
While each of the above factors has been found to independently affect IUGR, in 
interaction with each other the effects of these factors may well be greater than their 
independent effects. 
 
3.0 CLINICAL PROBLEMS / OUTCOMES OF THE SMALL FOR 
GESTATIONAL AGE NEONATE 
 
Mortality 
 
The consequences of small size for gestational age depend on the etiology, severity, 
and duration of growth restriction. There continues to be much debate on this subject. 
By now, many studies have been conducted over extended periods of changing 
perinatal management and increasing survival rates of smaller, more preterm infants, 
many of whom have been classified differently at different times and among different 
studies regarding their degree of IUGR. Some studies have indicated that the fetus 
responds to the “stress” of growth restriction with an acceleration of maturity, which 
24 
 
ultimately is protective for the infant. Others have found no evidence of improved 
survival after perinatal stress, and SGA status has been shown to be an independent 
predictor of increased fetal, perinatal, and neonatal death.
31
 On balance, there is little 
evidence to support the concept of improved survival after perinatal stress in SGA 
infants, and the perinatal mortality rate for SGA infants with relatively severe IUGR 
is 5 to 20 times that of AGA infants of the same gestational age.
32
 Particularly when 
adjusted for maternal neonatal risk factors of IUGR, including birth weight percentile, 
gestational age at birth, maternal height, prepregnancy weight, gestational weight 
gain, race, and parity, a subgroup of SGA infants is defined that has consistently and 
markedly higher perinatal mortality and morbidity rates than normally grown 
infants.
33 
 
Asphyxia 
SGA infants frequently do not tolerate labor and vaginal delivery, and signs of fetal 
distress are common. In such cases, the already stressed, chronically hypoxic infant is 
exposed to the acute stress of diminished blood flow during uterine contractions. Cord 
blood lactate concentrations are often increased despite overall normal cord blood pH. 
Preterm SGA infants are delivered by cesarean section twice as often as preterm AGA 
infants.
34
 SGA infants have an increased incidence of low Apgar scores at all 
gestational ages, and these infants frequently need resuscitation. The acute fetal 
hypoxia, acidosis, and cerebral depression may result in fetal death or neonatal 
asphyxia. Sequelae of perinatal asphyxia includes hypoxic-ischemic encephalopathy, 
heart failure from hypoxia-ischemia and glycogen depletion, meconium aspiration 
syndrome, persistent pulmonary hypertension, gastrointestinal hypoperistalsis and 
ischemia- induced necrosis leading to focal perforation, and acute renal tubular 
necrosis and renal failure. 
25 
 
 
Hypoglycemia 
 
Hypoglycemia is extremely common in SGA infants, increasing with the severity of 
IUGR. The risk of hypoglycemia is greatest during the first 3 days of life, but fasting 
hypoglycemia, with or without ketonemia, can occur repeatedly up to weeks after 
birth. Early hypoglycemia usually is as a result of diminished hepatic and skeletal 
muscle glycogen contents.
35
 Early hypoglycemia is aggravated by diminished 
alternative energy substrates, including reduced concentrations of fatty acids from the 
scant adipose tissue and decreased concentrations of lactate from the hypoglycemia. 
Hyper-insulinemia, increased sensitivity to insulin, or both may contribute to a greater 
incidence of hypoglycemia, although there are very few, if any, accurate measures of 
insulin sensitivity at different times and among different conditions in SGA infants to 
support such assumptions. 
 
SGA infants also demonstrate decreased gluconeogenesis, and resolution of persistent 
hypoglycemia is coincident with improved capacity for, and rates of, 
gluconeogenesis. Deficient counter regulatory hormones also contribute to the 
pathogenesis of hypoglycemia in SGA infants.
36
 Catecholamine release is deficient in 
these neonates during periods of hypoglycemia. Although basal glucagon levels may 
be elevated, exogenous administration of glucagon fails to enhance glycemia because 
of the decreased hepatic glycogen stores. 
 
Hyperglycemia 
 
Very preterm SGA infants have developmentally low insulin secretion rates and 
plasma insulin concentrations, which may underlie the relatively common problem of 
hyperglycemia in ELBW SGA infants.
37
 Higher concentrations of Counter regulatory 
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hormones, such as epinephrine, glucagon, and cortisol, also may contribute, although 
there is only limited evidence to support this commonly held assumption. In contrast, 
administration of insulin to even preterm SGA infants usually produces prompt 
decreases in glucose concentration, indicating at least normal and probably greater 
than normal insulin sensitivity.
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Nutritional Problems 
A rapid rate of glucose supply can lead to marked hyperglycemia, especially in the 
ELBW preterm SGA infant. On the other hand, amino acid intolerance is not 
exaggerated in SGA infants, despite some earlier evidence that amino acids are not 
used as readily for gluconeogenesis. If insulin and IGF-I are deficient in these infants, 
one would also expect lower anabolic rates until glucose and amino acid supplies and 
concentrations, and production rates of these growth factors, are restored. Similar 
issues may apply to lipid tolerance. Such considerations have prompted some 
reluctance to feed the SGA infant as aggressively as their deprived nutritional state 
would indicate, but large-scale, rigorous trials of different rates and amounts of 
nutrition to such infants have not been conducted. Such trials are needed to determine 
whether these infants will tolerate more aggressive feeding and whether this will 
result, safely, in improved nutritional rehabilitation, growth, and perhaps, neuro 
developmental outcome. 
 
Temperature Regulation 
Compared with term infants, SGA infants have a narrow thermo neutral range. Heat 
production cannot match the rate of heat loss with continued cold stress. The rapid 
heat loss as a result of the large head-to-body ratio and increased surface area seen in 
all infants is exaggerated in the SGA infant. Heat is also lost more quickly through a 
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thin layer of subcutaneous fat insulation. Because they are gestationally more mature 
than their preterm peers, SGA infants do have a more generous thermo neutral range 
for weight and are better able to maintain the increased metabolic rate necessary to 
increase heat production.
39
 Heat production may be impaired by concurrent conditions 
of hypoglycemia and hypoxia seen commonly in these patients. The normal response 
to cold involves increased muscular activity and catecholamine (nor epinephrine) 
release. Central nervous system depression may prevent this normal response to 
cold.
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Polycythemia 
SGA infants manifest an increased incidence of polycythemia. Increased red blood 
cell volume is likely related to chronic in utero hypoxia leading to increased 
erythropoiesis. Maternal-fetal transfusion may occur chronically with fetal hypoxia or 
more acutely with episodes of fetal distress. Even when not polycythemic (venous 
hematocrit greater than 60), SGA infants have higher than normal hematocrit. 
Approximately half of all term SGA infants have a central hematocrit above 60% and 
about 17% of term SGA infants have a central hematocrit above 65% in contrast to 
only about 5% in AGA term infants.
41
 Most polycythemic infants remain 
asymptomatic, but SGA infants are at greater risk of symptoms and clinical 
consequence. Interestingly, male SGA infants are at highest risk. Polycythemia 
contributes to hypoglycemia and hypoxia. Altered viscosity interferes with neonatal 
hemodynamics and results in abnormal postnatal cardiopulmonary and metabolic 
adaptation. 
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Infections 
Immunologic function of SGA infants may be depressed at birth and may persist into 
childhood, as in older infants with postnatal onset of malnutrition.
42
 Deficiencies have 
been demonstrated in lymphocyte number and function, which include decreased 
spontaneous mitogenesis and reduced response to phytohemagglutinin. Similarly, 
these infants tend to have lower immunoglobulin levels during infancy and 
demonstrate an attenuated antibody response to oral polio vaccine. 
 
Miscellaneous Problems 
At birth, cord prealbumin and bone mineral content are low in term SGA infants.
43
 
Calcium and iron stores may be low as a result of chronic decreased placental blood 
flow and insufficient nutrient supply. Significant hypocalcemia can occur after 
stressful birth complicated by acidosis. Thrombocytopenia, neutropenia, prolonged 
thrombin and partial thromboplastin times, and elevated fibrin degradation products 
are also problems among SGA infants.
44
 Sudden infant death syndrome may be more 
common after IUGR. Inguinal hernias also disproportionally follow preterm IUGR. 
 
TABLE 3. SUMMARY OF CLINICAL PROBLEMS OF THE SMALL- FOR 
GESTATIONAL- AGE NEONATE 
 
Problem Pathogenesis/ 
Pathophysiology 
Prevention/ 
Treatment 
Intrauterine death Chronic hypoxia 
Placental insufficiency 
Growth failure 
Malformation 
Infection 
Infarction/abruption 
Preeclampsia 
Antenatal surveillance 
Fetal growth by ultrasound 
Biophysical profile 
Doppler velocimetry 
Maternal treatment:  
Bedrest, O2 Delivery for 
severe/worsening fetal distress 
Perinatal Asphyxia Acute hypoxia/abruption 
Chronic hypoxia 
Placental 
insufficiency/Preeclampsia 
Acidosis 
Glycogen depletion 
Antepartum/intrapartum 
monitoring 
Adequate neonatal resuscitation 
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Meconium 
Aspiration  
Hypoxia Resuscitation including tracheal 
suctioning for aspiration 
Hypothermia Cold stress 
Hypoxia 
Hypoglycemia 
Decreased fat stores 
Decreased subcutaneous insulation 
Increased surface area 
Catecholamine depletion 
Protect against increased heat 
loss 
Dry infant – Radiant warmer, 
Hat 
Thermo neutral environment 
Nutritional support 
Persistent 
pulmonary 
hypertension 
Chronic hypoxia Cardiovascular support 
Mechanical ventilation, 
Nitric oxide 
Hypoglycemia Decreased hepatic/muscle 
glycogen 
Decreased alternative energy 
sources 
Heat loss; Hypoxia 
Decreased gluconeogenesis 
Decreased counter regulatory 
hormones 
Increased insulin sensitivity 
Frequent measurement of 
blood glucose 
Early intravenous glucose 
support 
Hyperglycemia Low insulin secretion rate 
Excessive glucose delivery 
Increased catecholamine 
Glucose monitoring 
Glucose infusion <10 mg/min/kg 
Insulin administration  
Polycythemia 
 
Chronic hypoxia 
Maternal-fetal transfusion 
Increased erythropoiesis 
Glucose, oxygen 
Partial volume exchange 
transfusion 
Acute renal failure Hypoxia/ischemia Cardiovascular support 
Immunodeficiency Malnutrition 
Congenital infection 
Early, optimal nutrition 
Specific antibiotic and 
immune therapy 
 
4.4 IMPLICATIONS OF IUGR 
IUGR and mortality and morbidity 
Ashworth
45
 reviewed 29 data sets to assess the risks of mortality and morbidity 
associated with IUGR. He estimated that for term infants66 weighing between 2000 
and 2499 g the risk of neonatal death is four times higher than that for infants 
weighing between 2500 and 2999 g. Infants weighing between 2000 and 2499 g have 
a ten times higher risk of dying in the neonatal period than those weighing between 
3000 and 3499 g. Ashworth presents data from 9 studies substantiating the 
observation that IUGR infants are more susceptible to diarrheal diseases and 
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respiratory tract infections. The studies indicate that IUGR infants are between 1.2 
and 3.6 times more likely to develop these infections. 
 
IUGR and physical development 
IUGR infants are found to be much more likely to exhibit growth deficiencies, which 
appear to be permanent. A study in Guatemala compared development at age 3 for 
children born with disproportional IUGR, proportional IUGR and those born normal 
(control). The study found that the group with disproportional IUGR recuperated from 
thinness within the first few months. However infants with proportional IUGR 
remained lighter and shorter and had a smaller head circumference than the infants in 
the other two groups.
10 
 
An Indian study by Bhargava et al.
30
 followed up small for date infants with a birth 
weight of  2000 g for 6 years and found significant growth retardation in comparison 
with children of the same age born with normal weight. They also displayed delayed 
skeletal growth and maturation between 6-10 years of age and impaired immune 
competence. 
 
However, the low socio-economic status of these children and the resultant lack of 
stimulation and opportunity to learn could have confounded these results. To avoid 
such a bias, Proos et al.
46
 studied growth and development of Indian children adopted 
in Sweden. 81% of these children, adopted in early infancy, were IUGR. They found 
significant differences with respect to height for age and weight for age at 2 years 
between children < 2000 g at birth and those > 2000 g at birth. This indicates that the 
effects of IUGR cannot be reversed by an ideal environment and postnatal nutrition. 
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Strauss and Dietz
19
 also found a significant growth difference in terms of height and 
weight in their study. Strauss and Dietz compared 220 IUGR children with their 
normal birth weight siblings, thereby controlling for confounders like genetic 
potential and environmental factors. While IUGR infants as a group tend to be shorter 
than their appropriate birth weight counterparts, they do exhibit partial catch up 
growth during the first two years of life.
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IUGR and cognitive development 
Subtle neuro cognitive deficiencies are found to be common in IUGR babies. 
Evidence from the Child Development Centre, Kerala
48
 shows that for IUGR babies, 
every 500g decrease in birth weight is associated with a corresponding decrease in the 
developmental status at one, two and five years of age. In the Guatemalan study, 
described above, Villar et al.
10
 found that children born with proportional IUGR 
obtained a lower IQ score at 3 years on the Composite Infant Scale as compared to 
children with disproportional IUGR who in turn scored lower than the control group. 
 
IUGR and adult morbidity: The Fetal Origins of Adult Disease 
The Barker Hypothesis
2
 states that many degenerative diseases in adults, such as 
Coronary Heart Disease (CHD), hypertension, stroke and Non Insulin    Dependent 
Diabetes Mellitus (NIDDM) are induced by the effects of under nutrition in fetal life 
and infancy, reflected as Low Birth Weight. This is explained by the effect of fetal 
“programming". Fetal programming refers to the process wherein in-utero exposure to 
under nutrition leads to permanent changes in metabolic and hormonal regulation 
systems in the body. 
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Nevertheless, at the end of the First World Congress a BMJ editorial
49
 commented 
that the evidence looked convincing, especially for the association between IUGR and 
blood pressure and non insulin dependent diabetes mellitus. The combined evidence 
therefore predicts that more heart disease and impaired glucose tolerance will be seen 
in India. 
 
This study was aimed at finding out the immediate outcome of IUGR babies and Risk 
factors associated with IUGR and its outcome. 
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5. MATERIALS AND METHODS 
Study Design: 
This is a Cross Sectional study.  
Place of study:  
This study was carried out in the Department of Pediatrics, Neonatal Unit, Tirunelveli 
Medical College Hospital. 
Study period:  
This study was carried out between November 2008 and October 2010.  
Sample size 
According to the following sample size calculation formula, 120 IUGR babies were 
included in the study.  
Sample size (n) = 4pq/d2     [p = prevalence.  q= 1-p   
 
d= error allowed (25% of p)] 
For the prevalence of 35%, sample size will be 119; for the prevalence is 40%, sample 
size will be 96.  So, based on the prevalence of 35%, 120 were included in this study.  
Inclusion Criteria 
• Newborns with IUGR defined by Birth weight less than 10
th
 percentile 
(Annexure: 2) and Ponderal Index admitted in the SNN ward of Tirunelveli 
Medical College Hospital. 
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Exclusion Criteria 
• Newborns with chromosomal abnormalities. 
• Newborns with congenital anomalies.    
  
METHOD OF DATA COLLECTION 
Among all the IUGR babies admitted in SNN during the above study period, the 120 
babies who satisfied the Inclusion criteria were selected by systematic random 
sampling. Informed consent of their parents was taken after explaining in detail about 
the method and procedures involved in the study in their vernacular language.  
The socio demographic profile and relevant information of individual babies and their 
respective mothers were collected by interviewing the mother using a structured 
proforma (Annexure: 1). The clinical details, complications and outcome at discharge 
were noted down. The following investigations were carried out for all the babies 
under study.  
Laboratory Investigation: 
1) CBC – Hb, PCV, TC, DC, Platelet Count, ESR 
2) Blood Sugar, Urea and Serum Creatinine 
3) Serum calcium 
4) Chest X Ray 
5) Total and Direct Bilirubin (Only for Icteric babies) 
6) Sepsis Screening (Only for the suspected sepsis babies) - Peripheral smear for 
band forms and Toxic granules, Blood culture and sensitivity, CSF Analysis 
with culture and sensitivity. 
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a) Hb: Hemoglobin less than 13 mg/dl was considered as Anemia.   
b) PCV: The value of PCV more than 65% was taken as Polycythemia.   
c) Total WBC count: A total count of < 5,000/cu.mm or >20,000/cu.mm was taken 
as abnormal and considered as suspicious of sepsis.  
d) Differential count: Differential count was considered mainly to find out 
Neutropenia which is indicative of sepsis. Absolute Neutrophil count less than 2000 
was considered as Neutropenia.  
e) Platelet Count: Platelet count less than 1,00,000 was considered as 
Thrombocytopenia.  
f) ESR: Micro ESR value more than 15mm at one hour was considered as sepsis.  
g) Blood Sugar: Blood sugar value less than 45 mg/dl in one or more occasions were 
considered as hypoglycemia.  
h) Blood Urea and Serum Creatinine: Value of Blood urea more than 40mg/dl 
associated with the value of Serum Creatinine more than 1mg/dl was considered as 
acute renal failure.  
i) Serum calcium: Serum Calcium less than 7mg/dl was considered as 
hypocalcaemia.  
j) Chest X- Ray: Chest X-ray was done in all babies .  
k) Total and Direct Bilirubin: The Total and Direct Bilirubin were taken for only 
the clinical icteric babies and categorized as having hyperbillirubinaemia based on 
Bilirubin Nomogram.   
36 
 
l) Peripheral smear for band forms and Toxic granules: Presence of band forms 
and toxic granules in peripheral smear study was considered as abnormal and 
considered as sepsis.  
m) Blood culture and sensitivity: Blood culture and sensitivity test was done only in 
the cases of suspected sepsis. For the blood culture, 1ml of blood was drawn form a 
peripheral vein. This was then incubated at 37
o
C under aerobic condition and 
subculture was made on Mac Conkey agar media after 24 hrs of incubation. If any 
growth occurred at 48 hrs, it was again subcultured in Mac Conkey agar. Cultures 
were taken as sterile if no growth occurred at 96 hrs. Anaerobic cultures were not 
done.  
n) CSF analysis and culture: CSF analysis also was done only in the cases of 
suspected sepsis. CSF was obtained by lumbar puncture performed aseptically with a 
24 gauze disposable needle. Sample was transported promptly to the laboratory for 
analysis and culture and sensitivity. 
OUTCOME MEASURES 
The following outcome measures were quantified in the study.  
1) Immediate Complications. 
2) Condition at discharge. 
3) Risk factors associated with IUGR – Maternal  
4) Risk factors associated with IUGR – Fetal. 
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Maternal Risk factors: 
The socio- demographic and antenatal characteristics of the mothers were analysed 
and the following maternal risk factors associated with IUGR were considered in this 
study. They are  
• Lower age (≤ 25) (mean) 
• Rural residence 
• Lower Education (≤ Primary school) 
• Lower Income (Monthly family income ≤ Rs. 3000) (mean) 
• Anemia (Hb ≤ 10mg/dl) 
• Lower Weight gain   (≤ 10 kg) 
• Malnutrition (Pre-pregnancy BMI ≤ 18.5) 
• Multiple Gestations 
• Heart Disease (RHD, CHD) 
• Pulmonary Disease (Bronchial asthma, COPD) 
• Pregnancy Induced Hypertension (BP >140/90 mm Hg)  
• Diabetes Mellitus (by History) 
• Tobacco Use (Using tobacco more than 2 yrs) 
• Long Infertility (Infertility > 8 yrs) and  
• UTI (from ANC record). 
Fetal Risk Factors: 
The fetal risk factors considered for analysis of this study were  
• Gender of the baby 
• Weight 
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• Gestational Age (by LMP and New Ballard scoring – Annexure 3) 
• Asymmetrical IUGR (Ponderal Index ≤ 2) [Ponderal Index = Weight in gm / 
{Legnth in cm}
3
 x 100] and  
• Mode of Delivery. 
Immediate Complications
*
:  
The important immediate complications considered were: 
• Metabolic: Hypoglycemia and Hypocalcaemia 
• Hematological: Neutropenia, Polycythemia, Anemia and Thrombocytopenia 
• Organ Dysfunction: Acute Renal Failure, Perinatal Asphyxia, Meconium 
Aspiration,   Pulmonary Hemorrhage, Persistent Pulmonary Hypertension and 
Respiratory Distress Syndrome. 
• Infection/ Others: Sepsis, Meningitis, Hypothermia and Hyperbillirubinaemia. 
 
Perinatal Asphyxia was considered when Apgar score was ≤ 3 at 5 minutes and 
requiring bag and mask ventilation; seizures within 24 - 48 hrs after birth in 
asphyxiated babies. The staging was done using Sarnat and Sarnat stages
50
 of 
Hypoxic Ischemic Encephalopathy (Annexure: 4).    
 
Meconium Aspiration syndrome was considered in babies born with meconium 
stained amniotic fluid associated with early onset respiratory distress (defined by 
Downes scoring) with poor lung compliance and hypoxemia with characteristic 
radiographic features in lungs (hyperinflation of lung fields with flattened diaphragms 
and coarse irregular patchy infiltrates).  
                                                            
*
 Definitions and reference values are based on NEONATOLOGY Management, Procedures, On-call 
Problems, Diseases and Drugs by Tricia lacy Gomela, Mc Graw Hill Lange International Edition – 6th 
Edition. 
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Pulmonary Hemorrhage was diagnosed by gross bloody secretions in the Endo 
Tracheal tube accompanied by respiratory decompensation requiring increased 
respiratory support. 
Persistent Pulmonary Hypertension was diagnosed by cyanosis with severe illness 
by clinical exam and prominent precordial impulse, loud S2 with single/ narrowly 
split and/ or a systolic murmur consistent with tricuspid regurgitation by cardiac 
examination and pre and posductal difference in oxygen saturation ≥ 10% in the 
absence of structural heart disease and confirmed by echocardiography.  
Respiratory Distress Syndrome was considered in preterm babies presenting with 
respiratory difficulty including tachypnoea (> 60 breaths/ minute), chest retractions 
with or without grunting, cyanosis in room air that persisted or progressed over the 
first 48 -96 hours of life with the characteristic chest radiography (uniform reticulo-
granular pattern and peripheral air bronchograms).    
Hypothermia was considered when axillary temperature < 36.5
0
C.  
CLINICAL OUTCOME: 
It was assessed in three aspects namely Dead, Abnormal neurological examination at 
discharge and Good condition at discharge. Babies who had some morbidity but 
improved clinically over the duration of stay in the hospital and taking feeds properly 
during discharge were categorized as discharged with good condition. Babies having 
poor feeding & sent along with antiepileptic drugs and showing abnormal 
neurological examination were categorized as Abnormal neurological examination at 
discharge. 
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Abnormal neurological examination includes:  
• asymmetries of posture or reflexes (marked or persistent) 
• decreased flexor or extremity tone or axial tone for post conceptional age 
• cranial nerve or oromotor dysfunction 
• abnormal sensory responses 
• abnormal behaviour (lethargy, irritability or jitteriness) and  
• extensor neck, trunk or extremity tone.   
(Amiel Tison angles – Annexure:  5) 
 
Statistical Methods:  
Data were entered in Excel spreadsheet and analysed using SPSS version 13.0. The 
results were analysed using the statistical test like simple proportions, Risk ratio and 
Chi-square test. The p- value < 0.05 was considered as statistically significant 
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6. OBSERVATIONS AND RESULTS  
 
1.0 General Characteristics  
1.1 Gender Distribution 
Gender Number Percent 
Male 65 54.2 
Female 55 45.8 
Total 120 100 
 
Among the total study population of 120 IUGR babies, 65 (54.2%) are males and 55 
(45.8%) are females. 
 
 
 
Fig 1.1 Showing the Gender distribution of the study population 
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1.2 Mothers – Distribution by Gravida 
Gravida Number Percent 
Primi 82 68.3 
2
nd
 Gravida 28 23.3 
3
rd
 Gravida 8 6.7 
4
th
 Gravida  2 1.7 
Total 120 100 
 
The above table shows the gestational age of the respective mothers of the study 
population. 82 (68.3%) mothers are primi and 28 (23.3%) are 2nd gravida mothers. 
The 3rd gravida mothers are 8 (6.7%) and only 2 (1.7%) are the 4th gravida mothers.  
 
 
Fig 1.2 Showing distribution of Mothers by Gravida 
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1.3 Mode of Delivery  
 
Mode of Delivery Number Percent 
Normal Vaginal 72 60.0 
Assisted 10 8.3 
LSCS 38 31.7 
Total 120 100 
 
Of the 120 babies, 72 (60.0%) have been delivered by normal vaginal delivery and 10 
(8.3%) have been delivered by Assisted delivery. 38 (31.7%) have been delivered by 
Caesarian section.   
 
 
Fig 1.3 Pie Diagram showing the Mode of Delivery 
 
 
44 
 
1.4 Distribution by Gestational Age 
Gestational Age 
Number Percent 
Preterm 22 18.3 
Term 98 81.7 
Total 120 100 
Of the total 120 babies 22 (18.3%) are Preterm babies and 98 (81.7%) are Term 
babies. 
 
 
 
 
Fig 1.4 Pie diagram showing proportion of Preterm 
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1.5 Distribution by Birth Weight 
Birth Weight Number Percent 
< 1000 gm 6 5.0 
1000 – 1499 gm 10 8.3 
1500 – 1999 gm 38 31.7 
2000 – 2500 gm 66 55.0 
Total 120 100 
 
 Of the 120 babies 66 (55.0%) are in the birth weight category of 2.0 - 2.5 kg and 38 
(31.7%) are in the birth weight category of 1.5 – 2.0 kg.  10 (8.3%) babies are in the 
category of 1.0 – 1.5 kg and 6 (5.0%) babies are in less than 1.0 kg category.  
 
 
 
Fig 1.5 Bar Diagram showing distribution of Birth Weight 
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1.6 Distribution of IUGR by Ponderal Index  
Ponderal Index Group Number Percent 
Asymmetrical  (PI ≤ 2) 82 68.3 
Symmetrical (PI > 2) 38 31.7 
Total 120 100 
Among the 120 study population 82 (68.3%) babies were classified as asymmetrical 
IUGR and 38 (31.7%) babies were classified as symmetrical IUGR as per Ponderal 
Index.  
 
 
Fig 1.6 Pie diagram showing distribution of IUGR by Ponderal Index 
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2.0 Morbidity and Mortality Pattern of IUGR 
2.1 Morbidity Pattern of IUGR  
Complications Number Percent 
Metabolic  
Hypoglycemia 76 63.3 
Hyperglycemia 10 8.3 
Hypocalcaemia 36 30.0 
Hematological  
Neutropenia 6 5.0 
Polycythemia 6 5.0 
Anemia 24 20.0 
Thrombocytopenia 30 25.0 
Organ Dysfunction  
Acute Renal Failure 22 18.3 
Perinatal Asphyxia 54 45.0 
Meconium Aspiration 20 16.7 
Pulmonary Hemorrhage 6 5.0 
Persistent Pulmonary 
Hypertension 
4 3.3 
Infection/ Others  
Sepsis 40 33.3 
Meningitis 6 5.0 
Hypothermia 34 28.3 
Hyperbillirubinaemia 20 16.7 
 
The above table shows that hypoglycemia (63.3%) and Perinatal Asphyxia (45.0%) 
are the commonest complication. Other commoner are Sepsis (33.3%), hypocalcaemia 
(30.0%), hypothermia (28.3%) and thrombocytopenia (25.0%).  
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Fig 2.1  Bar Diagram showing complications of IUGR 
 
 
2.2 Respiratory Distress Syndrome in Preterm (N= 22) 
RDS Number Percent 
Yes 7 31.8 
No 12 68.2 
Total 22 100 
Among the total 22 preterm babies 7 (31.8%) babies have Respiratory Distress 
Syndrome.  
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2.3 Mortality in IUGR 
 Number Percent 
Dead 22 18.3 
Discharged 98 81.7 
Total 120 100 
 
Of the 120 IUGR babies 22 (18.3%) have died at hospital and 98 (81.7%) have been 
discharged.  
 
   
 
Fig 2.2 Pie diagram showing the Mortality in IUGR 
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2.4 Outcome of IUGR 
Outcome 
Number Percent 
Dead 22 18.3 
Abnormal Neurological 
Exam.  at  Discharge 
19 15.3 
Good condition at 
Discharge  
79 66.3 
Total 120 100 
 
Of the 120 babies 22 (18.3%) have died in the hospital. 19 (15.5%) have been 
discharged with abnormal neurological examination and 79 (66.3%) have been 
discharged with Good condition at Discharge condition. 
 
 
Fig 2.3 Pie diagram showing Outcome of IUGR 
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2.5 Morbidity pattern and Outcome 
 
Complications 
Good 
condition at 
Discharge 
(N=79) 
Abnormal 
N E at 
Discharge 
(N=19) 
p – 
Value 
      Dead 
(N=22) 
 
p – 
Value 
Metabolic  
Hypoglycemia 52 (65.8%) 8 (42.1%) 0.057 16 (72.7%) 0.541 
Hyperglycemia 8 (10.1%)  2 (10.5) 0.959 0 (0.0%) 0.120 
Hypocalcaemia 21 (26.6%) 5 (26.3%) 0.981 10 (45.5%) 0.090 
Hematological  
Neutropenia 4 (5.1%) 0 (0.0%) 0.317 2 (9.1%) 0.480 
Polycythemia 3 (3.8%) 1 (5.3%) 0.772 2 (9.1%)  0.311 
Anemia 20 (25.5%) 4 (21.1%) 0.156 4 (18.2%) 0.482 
Thrombocytopenia 20 (25.5%) 2 (10.5%) 0.165 8 (36.4%) 0.318 
Organ Dysfunction  
Acute Renal Failure 14 (17.7%) 4 (21.1%) 0.736 4 (18.2%) 0.960 
Perinatal Asphyxia 27 (34.2%) 13 (68.4%) 0.006 14 (63.6%) 0.013 
Meconium 
Aspiration 
7 (8.9%) 9 (47.4%) 0.000 4 (18.2%) 0.215 
Pulmonary 
Hemorrhage 
0 (0.0%) 0 (0.0%) --- 6 (27.3%) 0.000 
Persistent Pulmonary 
Hypertension 
0 (0.0%) 0 (0.0%) --- 4 (18.2%) 0.000 
Infection/ Others  
Sepsis 24 (30.4%) 8 (42.1%) 0.328 8 (36.4%) 0.594 
Meningitis 2 (2.5%) 2 (10.5%) 0.114 2 (9.1%) 0.163 
Hypothermia 22 (27.8%) 8 (42.1%) 0.226 4 (18.2%) 0.359 
Hyperbillirubinaemia 10 (12.7%) 4 (21.1%) 0.348 6 (27.3%) 0.097 
 
The above table shows the distribution of various morbidity conditions of IUGR 
babies with their Outcome. Perinatal asphyxia and Meconium Aspiration are 
significantly associated with abnormal neurological examination at Discharge. 
Perinatal asphyxia, Pulmonary hemorrhage and Persistent pulmonary hypertension are 
significantly associated with Death during the hospital stay.  
52 
 
 
Fig 2.4 showing Morbidity pattern and Outcome 
 
3.0 Distribution of Maternal Risk Factors 
3.1 Maternal Risk Factors 
Maternal Risk factors Number Percent 
Anemia 41 34.2 
Malnutrition 48 40.0 
Multiple Gestations 10 8.3 
Heart Disease 8 6.7 
Pulmonary Disease 8 6.7 
PIH 22 18.3 
Diabetes Mellitus 2 1.7 
Tobacco Use 4 3.3 
Long Infertility 4 3.3 
UTI 6 5.0 
The above table shows the maternal risk factors associated with IUGR. Malnutrition 
is the commonest (48 – 40.0%) maternal risk factor. The other commoner are Anemia 
(41 – 34.2%), PIH (22 – 18.3%) and Multiple Gestations (10 – 8.3%).  
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Fig 3.1 Bar Chart showing distribution of  Maternal risk factors 
 
 
3.2 Number of Maternal risk factors 
Number of  
Maternal risk factors Number Percentage 
No Risk factor 27 22.5 
One  56 46.7 
Two 23 19.2 
Three  12 `10.0 
Four 2 1.7 
Total 120 100 
 
27 (22.5%) mothers didn’t have any specific risk factors. 56 (46.7%) mothers had 
only one risk factor and 23 (19.2%) had two risk factors. 3 risk factors were present in 
12 (10.0%) mothers and only 2 (1.7%) mothers have four risk factors.  
 
54 
 
 
Fig 3.2 Pie diagram showing the number of Maternal Risk factors 
 
 
4.0 Factors associated with Morbidity and Mortality pattern 
4.1.0 Maternal risk factors and Mortality 
Maternal 
Factors 
Death 
N= 22 
No Death 
N= 98 
Odds 
Ratio 
95% CI Chi-2 
Value 
P- 
Value 
Primi 16 (72.7%) 66 (67.3%) 1.29 0.46 – 3.62 0.240 0.624 
Lower Wt. gain 14 (63.6%) 62 (63.3%) 1.02 0.39 – 2.66 0.001 0.974 
Malnutrition 15 (68.2%) 33 (33.7%) 4.22 1.57 – 11.4 8.915 0.003 
Anemia 14 (63.6%) 27 (27.6%) 4.60 1.74 – 12.2 10.40 0.001 
PIH 6 (27.3%) 16 (16.3%) 1.92 0.65 – 5.66 1.438 0.230 
Multiple 
Gestations 
2 (9.1%) 8 (8.2%) 1.13 0.22 – 5.71 0.020 0.887 
From the above table, Primi gravida, Lower Wt. gain, Malnutrition, Anemia, PIH and 
Multiple gestations are the risk factors associated with mortality in IUGR. Among 
them Malnutrition and Anemia have significant association (p- value < 0.05).  
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4.1.1 Malnutrition and Outcome  
Malnutrition Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
Present 15 (31.3%) 10 (20.8%) 23 (47.9%) 48 (100%) 
Absent 7 (9.7%) 9 (12.5%)  56 (77.8%) 72 (100%) 
Total 22 (18.3%) 19 (15.8%) 79 (65.8%) 120 (100%) 
Chi
2
: 12.444       df: 2         p – Value: 0.002 
Malnutrition is significantly associated with mortality (p- value < 0.05). 
 
 
Fig. 4.1 Bar Chart showing Malnutrition and outcome. 
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4.1.2 Anemia and Outcome 
Anemia Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
Present 14 (34.1%) 5 (12.2%) 22 (53.7%) 41 (100%) 
Absent 8 (10.1%) 14 (17.7%) 57 (17.2%) 79 (100%) 
Total 22 (18.3%) 19 (15.8%) 79 (65.8%) 120 (100%) 
Chi
2
 – 10.417       df: 2         p – Value: 0.005 
 
Anemia is significantly associated with mortality (p- value < 0.05). 
 
 
Fig 4.2 Bar Chart showing Anemia and Outcome 
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4.1.3 Number of Maternal risk factors and Mortality 
Number of  
Maternal risk factors 
Dead 
(N=22) 
Alive 
(N=98) 
Total 
No Risk factor 6 (27.3%) 21 (21.4%) 27 (22.5%) 
One  5 (22.7%) 51 (52.0%) 56 (46.7%) 
Two 5 (22.7%) 18 (18.3%) 23 (19.2%) 
Three 4 (18.2%) 8 (8.2%) 12 (10.0%) 
Four 2 (9.1%) 0 (0.0%) 2 (1.7%) 
Total 22 (100%) 98 (100%) 120 (100%) 
      Chi
2
 – 14.762       df: 4         p – Value: 0.005 
 
The above table shows the relationship with the numbers of risk factors and mortality. 
There is a statistically significant association that the higher the number of maternal 
risk factors, higher the mortality (p- value < 0.001). 
 
 
Fig 4.3 Bar Diagam showing Number of Maternal risk factors and Outcome 
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4.2 Socio Demographic factors and Mortality 
Socio Demographic 
Factors 
Death 
N= 22 
No Death 
N= 98 
Odds 
Ratio 
95% CI Chi-2 
Value 
P- 
Value 
Lower Age  
(≤ 25 yrs) (Mean) 
14 (63.6%) 40 (40.8%) 2.54 1.12 – 6.61 4.260 0.042 
Residence -Rural 17 (77.3%) 64 (65.3%) 1.64 0.65 – 4.11 1.172 0.278 
Lower Income 
(≤ Rs. 3000) (Mean) 
19 (81.8%) 51 (55.1%) 4.16 1.31 – 
13.27 
5.343 0.006 
Lower Education 
(≤ Primary School) 
16 (72.7%) 67 (68.4%) 1.19 0.51 – 2.79 0.160 0.689 
 
The above table shows that the lower Age of the mother and the lower monthly 
income of the family are significantly associated with mortality in IUGR (p- value < 
0.05). 
 
4.3.0 Fetal risk factors and Mortality 
Fetal Factors Death 
N= 22 
No Death 
N= 98 
Odds 
Ratio 
95% CI Chi-2 
Value 
P- 
Value 
Sex- Male  13 (59.1%) 52 (53.1%) 1.28 0.50 – 3.26 0.263 0.608 
Weight ≤ 2 kg 15 (68.9%) 39 (39.8%) 3.24 1.11 – 9.76 5.850 0.015 
GA - Preterm  8 (36.4%) 14 (14.3%) 3.43 1.22 – 9.67 5.849 0.016 
Symmetrical 
IUGR  
10 (45.5%) 28 (28.6%) 2.08 0.81 – 5.37 2.367 0.124 
Normal 
Delivery 
18 (81.8%) 54 (55.1%) 3.67 1.16 – 11.63 5.343 0.021 
 
The above table shows that Weight ≤ 2 kg, Preterm, Normal delivery have the 
statistically significant association with mortality (p- value < 0.05).  
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4.3.1 Birth Weight and Outcome 
Birth Weight 
 
Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
< 1000 gm 6 (100%) 0 (0.0%) 0 (0.0%) 6 (100%) 
1000 – 1499 gm 3 (30.0%) 1 (10.0%) 7 (60.0%) 10 (100%) 
1500 – 1999 gm 8 (21.1%) 3 (7.9%) 27 (71.0%) 38 (100%) 
2000 – 2500 gm 5 (7.5%) 15 (22.8%) 46 (69.7%) 66 (100%) 
Total 22 (18.3%) 19 (15.8%) 79 (65.8%) 120 (100%) 
 
Chi
2
 – 36.160       df: 6         p – Value: 0.000 
 
The table shows that lower the weight more associated with Death during hospital and 
also this is statistically significant (p- value < 0.0001).  
 
 
 
Fig. 4.4 Bar Chart showing Birth weight and Outcome 
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4.3.2 Gestational Age and Outcome 
Gestational 
Age 
Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
< 32 weeks 7 (87.50%) 0 (0.0%) 1 (12.5%) 8 (100%) 
33- 37 weeks 6 (20.0%) 2 (6.7%) 22 (73.3%) 30 (100%) 
38- 40 weeks 8 (10.8%) 15 (20.3%) 51 (68.9%) 74 (100%) 
> 40 weeks 1 (12.5%) 2 (25.0%) 5 (62.5%) 8 (100%) 
Total 22 (18.3%) 19 (15.8%) 79 (65.8%) 120 (100%) 
Chi
2
 – 23.433       df: 6         p – Value: 0.001 
  
The above table  shows that the lower gestational age is significantly associated with 
higher chance of Death during hospital stay as compared to higher gestational ages (p- 
value < 0.01). 
 
 
Fig 4.5 Bar chart showing the Gestational age and Outcome. 
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4.3.3 Mode of Delivery and Outcome 
Mode of 
Delivery 
Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
Normal 18 (25.0%) 12 (16.7%) 42 (58.3%) 72 (100%) 
Assisted 4 (40.0%) 1 (10.0%) 5 (50.0%) 10 (100%) 
LSCS 0 (0.0%) 6 (15.8%) 32 (84.2%) 38 (100%) 
Total 22 (18.3%) 19 (15.8%) 79 (65.8%) 120 (100%) 
Chi
2
 – 14.465       df: 4         p – Value: 0.006 
The above table and the following picture show that Death is significantly associated 
with Normal delivery than other mode of deliveries (p- value < 0.01). 
 
 
 
Fig 4.6 Bar Chart showing the Mode of delivery and Outcome 
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4.4 Perinatal Asphyxia Stages and Outcome (N=54) 
HIE STAGE Dead Abnormal N E 
at Discharge 
Good condition 
at Discharge 
Total 
Stage I 0 (0.0%) 0 (0.0%) 21(100%) 21(100%) 
Stage II 5 (25.0%) 9 (45.0%) 6 (30.0) 20 (100%) 
Stage III 9 (69.2%) 4 (30.8%) 0 (0.0%) 13 (100%) 
Total 14 (25.9%) 13 (24.1%) 27 (50.0%) 54 (100%) 
Chi
2
: 42.390   df:4   p- value: 0.000 
The above table shows that Higher the HIE stage, higher the mortality in IUGR. This 
association is also statistically significant (p- value < 0.001). In the category of HIE 
Stage 3, all 4 have abnormal neurological examination, put on anti-epileptic drugs and 
having poor feeding. In the Stage 2 of 9, 2 are ANE, AED and PF; 7 AED of which 4 
had PF. 
 
Fig 4.7 Bar Chart showing the HIE Stages and Outcome 
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7. DISCUSSION 
7.1 General characteristics  
Of the 120 IUGR babies under the study, 65 (54.2%) are male and 55 (45.8%) are 
female. Among their respective mothers, 82 (68.3%) mothers are primi and 28 
(23.3%) are 2nd gravida mothers. The 3rd gravida mothers are 8 (6.7%) and only 2 
(1.7%) are the 4th gravida mothers.  
72 (60.0%) have been delivered by normal vaginal delivery and 10 (8.3%) have been 
delivered by Assisted delivery. 38 (31.7%) have been delivered by Caesarian section. 
22 (18.3%) are Preterm babies and 98 (81.7%) are Term babies. 
 66 (55.0%) are in the birth weight category of 2.0 - 2.5 kg and 38 (31.7%) are in the 
birth weight category of 1.5 – 2.0 kg.  10 (8.3%) babies are in the category of 1.0 – 
1.5 kg and 6 (5.0%) babies are in less than 1.0 kg category. 82 (68.3%) babies were 
classified as asymmetrical IUGR and 38 (31.7%) babies were classified as 
symmetrical IUGR as per Ponderal Index.  
Of the 120 IUGR babies 22 (18.3%) have died at hospital and 98 (81.7%) have been 
discharged. Of these 98 babies, 79 (66.3%) have been discharged with good condition  
and 19 (15.5%) with abnormal neurological examination.  
7.2 Morbidity and Mortality Pattern 
Regarding the complications, Hypoglycemia (63.3%) and Perinatal Asphyxia (45.0%) 
are the commonest of the complications observed in this study. Carbohydrate 
metabolism is seriously disturbed and these infants are highly susceptible to 
hypoglycemia as the consequence of diminished glycogen reserves and decreased 
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capacity to gluconeogenesis.
35
 IUGR infants frequently do not tolerate labor and 
vaginal delivery, and signs of fetal distress are common. 
Other commoner are Sepsis (33.3%), hypocalcaemia (30.0%), hypothermia (28.3%) 
and thrombocytopenia (25.0%). Other complications are Hyperglycemia (10 - 8.3%), 
Neutropenia (6 - 5.0%), Polycythemia (6 - 5.0%), Anemia (24 - 20.0%), Acute Renal 
Failure (22 - 18.3%), Meconium Aspiration (20 - 16.7%), Pulmonary Hemorrhage (6 - 
5.0%), Persistent Pulmonary Hypertension (4 - 3.3%) and Meningitis (6 - 5.0%).  
There are totally 22 preterm babies. Among them only 7 (31.8%) babies have 
Respiratory Distress Syndrome. This is due to as McIntire DD et al
51
 explained in 
their study that in IUGR babies, accelerated fetal pulmonary maturation occurs 
secondary to chronic intra uterine stress.  
Perinatal asphyxia and Meconium Aspiration are significantly associated with 
abnormal neurological examination at Discharge. Perinatal asphyxia, Pulmonary 
hemorrhage and Persistent pulmonary hypertension are significantly associated with 
Death during the hospital stay. 
7.3 Factors associated with Morbidity and Mortality pattern of IUGR 
7.3.1 Maternal factors 
Malnutrition is the commonest (48 – 40.0%) maternal risk factor in this study. 
Malnutrition during uterine growth leads to the onset of stunting which is not 
completely reversed even with long term exposure to good nutrition.
52
 According to 
Jane Harding
17
, fetal nutrition is the end result of a precarious supply chain, of which 
maternal nutrition and intake during pregnancy is only the starting point. Maternal 
malnutrition leads to deficient substrate supply to the fetus.  
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The other commoner maternal risk factors are Anemia (41 – 34.2%), PIH (22 – 
18.3%) and Multiple Gestations (10 – 8.3%).  In a study done by Deborah Watson 
Jones et al
64
, Anemia was observed in women who had adverse birth outcomes, 
33.8% had moderate to severe anemia. PIH results in decreased utero placental bold 
flow which results in impaired delivery of oxygen and other essential nutrients which 
in turn limit organ growth and musculo skeletal maturation.
53
 Impaired growth results 
from failure to provide optimal nutrition for more than one fetus in utero and the 
smaller twin has decreased nutrient delivery.  Others factors found in this study are 
Heart Disease (8 - 6.7%), Pulmonary Disease (8 - 6.7%), Diabetes Mellitus (2 -1.7%), 
Tobacco Use (4- 3.3%), Long Infertility (4 - 3.3) and UTI (6- 5.0%).  
27 (22.5%) mothers didn’t have any specific risk factors. 56 (46.7%) mothers had 
only one risk factor and 23 (19.2%) had two risk factors. 3 risk factors were present in 
12 (10.0%) mothers and only 2 (1.7%) mothers have four risk factors. Table 4.1.3 
shows the relationship with the numbers of risk factors and mortality. There is a 
statistically significant association that the higher the number of maternal risk factors, 
higher the mortality (p- value < 0.001) 
Primi gravida, Lower Wt. gain, Malnutrition, Anemia, PIH and Multiple gestations 
are the risk factors associated with mortality in IUGR (Table 4.1). Among them 
Malnutrition and Anemia have significant association (p- value < 0.05). Gawande et 
al
54
 found in their study that primi gravida is more common in IUGR and significantly 
associated with morbidity.  Bakketeig LS
 
et al
55
 in their study proved that Lower 
weight gain is one of the important factors associated with IUGR. Maternal 
malnutrition and Anemia in particular has been established as a critical factor behind 
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IUGR problem in India in other studies done by Acharya D et al
56
 at Karnataka, 
Ferriera AMA et al
57
 at and CSSM review report.
58 
4.3.2 Sociodemographic factors 
The lower Age of the mother and the lower monthly income of the family are 
significantly associated with mortality in IUGR (p- value < 0.05) (Table 4.2). Lower 
maternal age and its relationship with mortality in IUGR has been proved in the study 
done by Gawande et al
54
. Families with IUGR infants tend to be more disadvantaged 
in income, housing, parental education etc. than families of appropriately grown 
infants.
59 
4.3.3 Fetal factors 
Weight ≤ 2 kg, Preterm and Normal delivery have the statistically significant 
association with mortality (p- value < 0.05) (Table 4.3). Hack M, Fanaroff AA
60
 in 
their study on outcome of extremely low birth weight and gestational age IUGR 
babies found that lower birth weight and lower gestational age are significantly 
associated with morbidity and mortality. It is consistent with study done by McIntire 
DD et al.
51
  Table 4.3.1 details how the birth weight is associated with mortality 
during hospital.    
Table 4.3.2 depicts how lower gestational age is significantly associated with higher 
chance of Death during hospital stay as compared to higher gestational ages.  Garite 
TJ et al
61
 found that preterm infants have higher incidence of abnormalities than the 
general population because they are subjected to the risk of prematurity in addition to 
the risks of IUGR. IUGR infants delivered before 28 – 30 weeks had worse outcomes. 
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In this study also, of the 8 Infants born before 32 weeks, 7 have died. This is 
statistically significant (p- value < 0.01). 
Morbidity in IUGR is significantly associated with Normal delivery (Table 4.3.3) than 
other mode of deliveries (p- value < 0.01). IUGR babies frequently have birth 
asphyxia as they tolerate the stress of labour poorly. This is consistent with other 
studies by Hawdon JM et al
62
 and Pérez-Escamilla R et al
63
. This may be due to 
labour is stressful for IUGR fetuses. Skilled resuscitation should be available because 
perinatal depression is common. The availability of pediatrician for the skillful 
resuscitation also may contribute for the favorable outcome of IUGR in assisted 
delivery / caesarian section.  
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8. CONCLUSIONS  
 
The following are the observations and conclusions of the study. 
1. In this study, of the 120 IUGR babies 65 (54.2%) are male and 55 (45.8%) are 
female. 
 
2. According to Ponderal Index 82 (68.3%) babies are asymmetrical IUGR and 
38 (31.7%) are symmetrical IUGR. Ratio Asymmetrical: symmetrical = 
2.15:1.  Symmetrical IUGR is 2.08 times more risk of having mortality as 
compared to asymmetrical IUGR.  
 
 
3. Hypoglycemia (63.3%) and Perinatal Asphyxia (45.0%) are the commonest 
complications of IUGR. Other commoner are Sepsis (33.3%), hypocalcaemia 
(30.0%), hypothermia (28.3%) and thrombocytopenia (25.0%). 
 
4. Of the 120 babies, 22 (18.3%) died at hospital and 98 (81.7%) have been 
discharged. Of these 98 babies, 79 (66.3%) have been discharged in good 
condition and 19 (15.5%) with abnormal neurological examination.   
 
5. Perinatal asphyxia and Meconium Aspiration are significantly associated with 
abnormal neurological examination at Discharge. Perinatal asphyxia, 
Pulmonary hemorrhage and Persistent pulmonary hypertension are 
significantly associated with Death during the hospital stay.  
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6. Malnutrition is the commonest (40.0%) maternal risk factor in this study. The 
other commoner are Anemia (34.2%), PIH (18.3%) and Multiple Gestations 
(8.3%).   
 
7. 73 (77.5%) mothers had one or more risk factors. There is a statistically 
significant association that the higher the number of maternal risk factors, 
higher the mortality in IUGR. 
 
8. Malnutrition and Anemia are the statistically significant maternal factors 
associated with mortality in IUGR.  
 
9. Lower age of the mother and the lower monthly income of the family are 
significantly associated with mortality.  
 
10. Lower gestational age, Normal delivery and Lower weight of the baby are the 
statistically significant fetal risk factors associated with mortality.  
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9. RECOMMENDATIONS 
 
From the conclusions arrived at this study, the following recommendations can be 
made to prevent the incidence and the complications in IUGR.  
1. Hypoglycemia, hypocalcaemia and hypothermia are the common treatable 
complications in this study which can be easily identified and treated. So in 
IUGR babies it is important to anticipate these conditions and treat 
appropriately to prevent further morbidity and mortality.  
 
2. Perinatal asphyxia is the second most common complication observed in this 
study which is significantly associated with morbidity and mortality. Hence 
anticipating perinatal asphyxia, effective neonatal resuscitation measures 
should be made available for every IUGR delivery.   
 
3. Malnutrition and Anemia are the most common maternal risk factors in this 
study and significantly associated with mortality in IUGR. As these are the 
preventable risk factors, the nutritional status of the prospective mothers 
should be given utmost importance.  
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10. LIMITATIONS 
 
Placental factors significantly contribute to IUGR, but only non - Placental factors 
associated with IUGR have been considered in this study due to the inclusion of out 
born babies also. 
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ANNEXURE: 1  
PROFORMA – IUGR STUDY 
 
IP No :        S. No :  
Name :         Sex : M / F 
DOB :   Time: 
Age of Mother:  Yrs.  G: P: L: A: 
Education :   Illiterate/ Primary/Middle/High School/ HSS /Diploma  / Graduate 
Occupation :    House-wife  /  Coolie / Farmer  /  Employed / Business / 
Husband’s Occupation:    Coolie / Farmer  /  Employed / Business  / 
Total monthly Income: 
Religion  : Hindu    /   Christian    / Muslim     / Others     
Gestational age :       wks.   LMP:    EDD:   
Prepregnancy Wt :         Kgs.  Height :       Cm 
Wt gain during pregnancy :     Kgs.  
Hemoglobin  :            gm% 
Mode of Delivery  :  Normal Vaginal / Assisted / Caesarean 
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Risk Factors in Mother: 
Malnutrition  Pregnancy induced 
Hypertension 
 
Multiple Gestations  Diabetes Mellitus  
Uterine Anomalies  Long Infertility  
Anemia  Thrombotic Disease  
Heart Disease (RHD, CHD)  Collagen vascular Disease  
Renal Disease   Tobacco/Cocaine use  
Pulmonary disease (Bronchial 
Asthma, COPD) 
 UTI  
 
CLINICAL EXAMINATION: 
Birth Weight  :    APGAR Score:  1 Min:          5 Min: 
HC:     CC:    Length: 
Ponderal Index:      CANS Score: 
Cry:    Fair/ Weak / Absent    Activity:   Fair / Weak  / Absent  
Colour:    Pink   / Cyanosed / Plethoric  
Temperature:   Normothermic / Hypothermic / Hyperthermic  
RS:     CVS:    Abdomen:   
LABORATORY INVESTIGATIONS: 
1) CBC - Hb, PCV, TC, DC, Platelet Count, ESR. 
2) Blood sugar 
3) Blood Urea 
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4) Serum Creatinine 
5) Serum Electrolytes 
6) Serum calcium 
7) Sepsis Screening (in probable sepsis)  
a. TC 
b. Micro ESR,  
c. Peripheral smear for band forms  
d. Toxic granules 
e. Blood culture and sensitivity 
f. CSF Analysis  
g. CSF culture and sensitivity 
h. CXR. 
COMPLICATIONS: 
Perinatal depression  Hypocalcemia  
Meconium aspiration  Polycythemia  
Pulmonary Hemorrhage  Thrombocytopenia  
Persistent Pulmonary hypertension  Hyperbilirubinemia  
Hypothermia  Sepsis  
 
OUTCOME: Dead / Abnormal neurological examination at Discharge/ Good 
condition at Discharge. 
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ANNEXURE: 2  
INTRA UTERINE GROWTH CHARTS – LUBCHENCO 
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ANNEXURE: 3  
 
ASSESSMENT OF GESTATIONAL AGE - NEW BALLARD’S SCORING 
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ANNEXURE: 4  
 
 SARNAT AND SARNAT STAGING OF HYPOXIC ISCHEMIC ENCEPHALOPATHY 
 
 State 1 Stage 2 Stage 3 
Level of 
Consciousness 
Hyperalert Lethargic or obtunded Stuporous 
Neuromuscular Control 
Muscle tone Normal Mild hypotonia Flaccid 
Posture Mild distal 
flexion 
Strong distal flexion Intermittent 
decerebration 
Stretch reflexes Overactive Overactive Decreased or absent 
Segmental myoclonus Present Present Absent 
Complex Reflexes 
Suck Weak Weak or absent Absent 
Moro Strong; low 
threshold 
Weak; incomplete; high 
threshold 
Absent 
Oculovestibular Normal Overactive Weak or absent 
Tonic neck Slight Strong Absent 
Autonomic Function Generalized 
sympathetic 
Generalized 
parasympathetic 
Both systems depressed 
Pupils Mydriasis Miosis Variable; often unequal; 
poor light reflex 
Heart Rate Tachycardia Bradycardia Variable 
Bronchial and 
Salivary Secretions 
Sparse Profuse Variable 
GI Motility Normal or 
decreased 
Increased; diarrhea Variable 
Seizures None Common; focal or 
multifocal 
Uncommon (excluding 
decerebration) 
EEG Findings Normal (awake) Early: low-voltage 
continuous delta and theta 
Later: periodic pattern 
(awake) 
Seizures: focal 1-to 1-Hz 
spike-and-wave 
Early: periodic pattern 
with Isopotential phases 
Later: totally isopotential 
Duration 1-3 days 2-14 Hours to weeks 
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ANNEXURE: 5   
 
ABNORMAL NEUROLOGICAL EXAMINATION - Amiel Tison angles 
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